Study Results Demonstrate Greater Potential of New Diabetes Therapy Beyond Glucose Control

Nov 08, 2010, 07:00 ET from Novo Nordisk Canada Inc.

Meta-Analysis Presented at the CDA/CSEM Professional Conference and Annual Meetings Provides Insight into GLP-1 Therapy Advances

MISSISSAUGA, ON, Nov. 8 /PRNewswire/ -

To view this Social Media Release, please enter the following address in your web browser.

SOURCE Novo Nordisk Canada Inc.